CIK 0001878313
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAIA Biotechnology, Inc.
Sign in to watch- Ticker
- MAIA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 312-416-8592
- Business address
- 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
- 4/A Open-market buy Director bought 73,333 shares at $1.50 ($110,000)
- 4 Open-market buy Director bought 73,333 shares at $1.50 ($110,000)
- 4 Open-market buy Director bought 50,000 shares at $1.50 ($75,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 25,000 shares at $1.87 ($46,800)
- 4 Open-market buy Director bought 53,418 shares at $1.87 ($99,998)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 22,133 shares at $2.51 ($55,554)
- 4 Open-market buy Director bought 22,133 shares at $2.51 ($55,554)
- 4 Open-market buy Director bought 88,534 shares at $2.51 ($222,220)
- 4 Open-market buy Director bought 100,000 shares at $2.51 ($251,000)
- 4 Derivatives Options or other derivatives
Page 5 of 13 · 248 filings